talazoparib,enzalutamide
pfizer,astellas
['prostate', 'pfizer']
see our oral presentation on results from a phase 3 study in men with hrr gene-mutated metastatic castration-resistant #prostatecancer receiving parpi + androgen receptor inhibitor (ari) vs ari + placebo at #asco23.
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ